SELLAS Life Sciences Group, Inc. (SLS) Tops Q1 EPS by 2c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Deutsche Bank monitors UK auto sales as Chinese exports grow
• RenX Enterprises agrees to sell Georgia property for $2.6M
• LivePerson extends special meeting deadline for SoundHound AI merger vote